Some possible heartening news for those of us in the UK. NICE are currently reviewing the immunotherapy drug retifanlimab and expect to give a decision around the 16th December 2026. In the meantime there is the possibility that they may allow certain hospitals to prescribe it on compassionate grounds again, after closing this in November last year. Hope this will help so many of us.
Whatever cancer throws your way, we’re right there with you.
We’re here to provide physical, financial and emotional support.
© Macmillan Cancer Support 2026 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 3rd Floor, Bronze Building, The Forge, 105 Sumner Street, London, SE1 9HZ. VAT no: 668265007